Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of ProKidney Corp (NASDAQ: PROK) was $2.20 for the day, up 2.33% from the previous closing price of $2.15. In other words, the price has increased by $2.33 from its previous closing price. On the day, 0.57 million shares were traded. PROK stock price reached its highest trading level at $2.37 during the session, while it also had its lowest trading level at $2.035.
Ratios:
Our analysis of PROK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.94 and its Current Ratio is at 14.94.
On July 25, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $16.BTIG Research initiated its Buy rating on July 25, 2023, with a $16 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 22 ’24 when Weber Darin J. sold 16,438 shares for $2.51 per share. The transaction valued at 41,315 led to the insider holds 155,194 shares of the business.
Weber Darin J. sold 800 shares of PROK for $2,028 on Apr 18 ’24. The SVP of Regulatory Development now owns 171,632 shares after completing the transaction at $2.54 per share. On Apr 16 ’24, another insider, Weber Darin J., who serves as the SVP of Regulatory Development of the company, sold 17,238 shares for $2.50 each. As a result, the insider received 43,095 and left with 172,432 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 1811825408 and an Enterprise Value of 1271761920.
Stock Price History:
The Beta on a monthly basis for PROK is 1.11, which has changed by -0.7712766 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $13.51, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is 23.83%, while the 200-Day Moving Average is calculated to be -41.49%.
Shares Statistics:
PROK traded an average of 741.09K shares per day over the past three months and 959060 shares per day over the past ten days. A total of 59.88M shares are outstanding, with a floating share count of 43.34M. Insiders hold about 29.67% of the company’s shares, while institutions hold 57.35% stake in the company. Shares short for PROK as of 1713139200 were 11559104 with a Short Ratio of 15.60, compared to 1710460800 on 14606416. Therefore, it implies a Short% of Shares Outstanding of 11559104 and a Short% of Float of 18.84.
Earnings Estimates
The current market rating for ProKidney Corp (PROK) reflects the collective analysis of 1.0 analysts closely monitoring its performance.On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.18, while EPS last year was -$0.16. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.73 and -$2.18 for the fiscal current year, implying an average EPS of -$1.15. EPS for the following year is -$0.83, with 3.0 analysts recommending between -$0.6 and -$1.17.
